Shandong Sanyuan Biotechnology Co.,Ltd.
SZSE:301206.SZ
27.83 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 496.812 | 674.906 | 1,675.32 | 783.182 | 476.76 | 292.204 | 120.955 | 88.904 | 40.078 | 20.061 | 19.205 |
| Cost of Revenue
| 493.357 | 580.046 | 971.829 | 452.143 | 258.532 | 184.526 | 82.921 | 63.352 | 32.816 | 15.661 | 15.043 |
| Gross Profit
| 3.456 | 94.859 | 703.491 | 331.039 | 218.228 | 107.678 | 38.034 | 25.552 | 7.262 | 4.399 | 4.162 |
| Gross Profit Ratio
| 0.007 | 0.141 | 0.42 | 0.423 | 0.458 | 0.369 | 0.314 | 0.287 | 0.181 | 0.219 | 0.217 |
| Reseach & Development Expenses
| 43.719 | 34.078 | 59.001 | 30.34 | 19.449 | 14.987 | 12.038 | 0 | 0 | 0.591 | 0.671 |
| General & Administrative Expenses
| 2.591 | 4.729 | 4.238 | -17.113 | -9.062 | -7.642 | -5.751 | 6.713 | 3.964 | 0.321 | 0.364 |
| Selling & Marketing Expenses
| 5.583 | 5.194 | 5.468 | 3.886 | 16.777 | 10.654 | 5.403 | 2.821 | 1.11 | 0.717 | 1.007 |
| SG&A
| 19.015 | 9.923 | 9.706 | -13.227 | 7.715 | 3.012 | -0.348 | 9.535 | 5.074 | 1.039 | 1.371 |
| Other Expenses
| -0.151 | -2.098 | 0.125 | 26.02 | -7.479 | -7.01 | 0.3 | 0 | 0 | 0.284 | 0.284 |
| Operating Expenses
| 62.885 | 46.442 | 78.329 | 48.405 | 45.266 | 30.705 | 15.981 | 10.286 | 5.275 | 3.57 | 3.543 |
| Operating Income
| -59.429 | 186.053 | 619.771 | 273.125 | 159.16 | 78.595 | 21.838 | 14.886 | 2.09 | 0.233 | 0.071 |
| Operating Income Ratio
| -0.12 | 0.276 | 0.37 | 0.349 | 0.334 | 0.269 | 0.181 | 0.167 | 0.052 | 0.012 | 0.004 |
| Total Other Income Expenses Net
| 122.399 | -2.098 | 0.125 | -2.981 | -1.019 | -0.101 | 0.105 | 0.5 | -0.053 | 0.284 | 0.284 |
| Income Before Tax
| 62.97 | 183.955 | 619.897 | 270.144 | 158.141 | 78.494 | 21.943 | 15.387 | 2.037 | 0.516 | 0.355 |
| Income Before Tax Ratio
| 0.127 | 0.273 | 0.37 | 0.345 | 0.332 | 0.269 | 0.181 | 0.173 | 0.051 | 0.026 | 0.018 |
| Income Tax Expense
| 2.837 | 20.269 | 84.482 | 37.572 | 21.834 | 10.405 | 3.239 | 1.445 | 0 | 0.922 | 0.656 |
| Net Income
| 58.874 | 163.687 | 535.415 | 232.573 | 136.307 | 68.088 | 18.704 | 13.942 | 2.037 | 0.516 | 0.355 |
| Net Income Ratio
| 0.119 | 0.243 | 0.32 | 0.297 | 0.286 | 0.233 | 0.155 | 0.157 | 0.051 | 0.026 | 0.018 |
| EPS
| 0.29 | 0.81 | 2.65 | 1.15 | 0.67 | 0.46 | 0.13 | 0.16 | 0.033 | 0.017 | 0.012 |
| EPS Diluted
| 0.29 | 0.81 | 2.65 | 1.15 | 0.67 | 0.46 | 0.13 | 0.16 | 0.033 | 0.017 | 0.012 |
| EBITDA
| 0.176 | 219.157 | 646.164 | 299.804 | 198.91 | 84.36 | 25.194 | 15.466 | 3.439 | 2.453 | 1.853 |
| EBITDA Ratio
| 0 | 0.325 | 0.386 | 0.383 | 0.417 | 0.289 | 0.208 | 0.174 | 0.086 | 0.122 | 0.096 |